Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: An open label, single arm, phase II trial.
Clinical Lymphoma, Myeloma and Leukemia.
Times cited: 20
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: Mediastinal localization predicts for a favorable outcome.
Journal of Clinical Oncology.
Times cited: 59